Wednesday, April 22

Browsing: Cadonilimab

Treatments

Cadonilimab Yields 100% 24-Month OS in Recurrent Cervical Cancer Population

By NewsCancerMarch 5, 20260

Cadonilimab (AK104), a first-in-class bispecific antibody targeting PD-1 and CTLA-4, demonstrated a 100% 24-month overall survival (OS) rate in those…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.

What's Hot

Maintenance capecitabine after first-line platinum-based chemotherapy in advanced oesophagogastric adenocarcinoma: final analysis from the PLATFORM trial

Work, Money, & a Normal Life

AACR in 30 Seconds: Revolution Medicines data, NCI director, wildfires

Browsing: Cadonilimab

Cadonilimab Yields 100% 24-Month OS in Recurrent Cervical Cancer Population

Maintenance capecitabine after first-line platinum-based chemotherapy in advanced oesophagogastric adenocarcinoma: final analysis from the PLATFORM trial

Work, Money, & a Normal Life

AACR in 30 Seconds: Revolution Medicines data, NCI director, wildfires

HDAC8 inhibition targets STAT3–MYC axis and synergizes with Venetoclax in KMT2A-rearranged acute myeloid leukemia

Maintenance capecitabine after first-line platinum-based chemotherapy in advanced oesophagogastric adenocarcinoma: final analysis from the PLATFORM trial

Work, Money, & a Normal Life

AACR in 30 Seconds: Revolution Medicines data, NCI director, wildfires

HDAC8 inhibition targets STAT3–MYC axis and synergizes with Venetoclax in KMT2A-rearranged acute myeloid leukemia

Latest Post

Maintenance capecitabine after first-line platinum-based chemotherapy in advanced oesophagogastric adenocarcinoma: final analysis from the PLATFORM trial

Work, Money, & a Normal Life

AACR in 30 Seconds: Revolution Medicines data, NCI director, wildfires

Subscribe to Updates

What's Hot

Browsing: Cadonilimab